Conference

New vaccines pipeline on the agenda at Pfizer event

Pfizer In Merger Talks With Allergan PLC
NEW YORK, NY - OCTOBER 29: The Pfizer headquarters in New York City stands in the heart of Manhattans business district on October 29, 2015 in New York City. Ireland-based Allergan confirmed October 29, that it has been approached by the U.S. drug company Pfizer and is in talks regarding a potential deal. These are just the latest two pharmaceutical companies to start early dealmaking talks. (Photo by Spencer Platt/Getty Images)

A major priority for healthcare globally over the next five years must be that we make positive use of the vaccines we already have, a leading expert told Hospital Professional News at an event at Pfizer in Dublin.

Dr Stephen Lockhart put forward the opinion as part of a stellar line-up at the event. This included some of the world’s leading vaccine experts, who offered insight into how governments use national immunisation programmes to manage disease, and the importance of vaccination in preventing antimicrobial resistance.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free